Gsk Reddy's Suntorent Pharma Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2021.
2021 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Gsk Reddy's Suntorent Pharma Private Limited

Gsk Reddy's Suntorent Pharma Private Limited, a active private limited company, was established on 14 April 2021 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24297MH2021PTC358932. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Safalta Yashwant Ambatkar (Director), Yashwant Dadaji Ambatkar (Director). It is based at Shop No. 1, Madhuvatsal Appartment 187, Tukdoji Chowk, Nagpur, Maharashtra, 440027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24297MH2021PTC358932

  • Registration Number

    358932

  • Incorporation Date

    14 April 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 4 Year, 10 Months
Company report

Gsk Reddy's Suntorent Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gsk Reddy's Suntorent Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gsk Reddy's Suntorent Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Safalta Yashwant Ambatkar Director 14 Apr 2021 Current
Yashwant Dadaji Ambatkar Director 14 Apr 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gsk Reddy'S Suntorent Pharma.

Enhance accessibility to Gsk Reddy'S Suntorent Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gsk Reddy'S Suntorent Pharma revenue growth over time
Gsk Reddy'S Suntorent Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gsk Reddy'S Suntorent Pharma?

Unlock access to Gsk Reddy'S Suntorent Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gsk Reddy'S Suntorent Pharma?

Gsk Reddy'S Suntorent Pharma has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gsk Reddy'S Suntorent Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsk Reddy'S Suntorent Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gsk Reddy'S Suntorent Pharma
Recent Activity within the Organization
  • Director Appointment

    Safalta Yashwant Ambatkar was appointed as a Director was appointed as a Director on 14 Apr 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Director Appointment

    Yashwant Dadaji Ambatkar was appointed as a Director was appointed as a Director on 14 Apr 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Gsk Reddy'S Suntorent Pharma Private Limited was registered on 14 Apr 2021 with Roc Mumbai & aged 4 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gsk Reddy's Suntorent Pharma Private Limited?

The CIN of Gsk Reddy's Suntorent Pharma Private Limited is U24297MH2021PTC358932.

Where is Gsk Reddy's Suntorent Pharma Private Limited headquartered?

Gsk Reddy's Suntorent Pharma Private Limited is headquartered at Shop No. 1, Madhuvatsal Appartment 187, Tukdoji Chowk, Nagpur, Maharashtra, 440027.

When was Gsk Reddy's Suntorent Pharma Private Limited incorporated?

Gsk Reddy's Suntorent Pharma Private Limited was incorporated on 14 April 2021.

Who are the current directors of Gsk Reddy's Suntorent Pharma Private Limited?

The current directors of Gsk Reddy's Suntorent Pharma Private Limited are

What is the primary industry of Gsk Reddy's Suntorent Pharma Private Limited?

The primary industry of Gsk Reddy's Suntorent Pharma Private Limited is Pharma.

Is Gsk Reddy's Suntorent Pharma Private Limited a listed company?

Gsk Reddy's Suntorent Pharma Private Limited is unlisted.

What is the capital structure of Gsk Reddy's Suntorent Pharma Private Limited?

The authorized capital of Gsk Reddy's Suntorent Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available